2024 / 2025 Lineup
Free CME/CE Education On-Demand
Explore Our CME/CE On-Demand Lineup
Select a tile below to find out more!
Featured Activities
PROSTATE CANCER
Improving Outcomes in Advanced Prostate Cancer: Patient Case Simulations
In this immersive educational program, participants will expand their understanding of managing patients with Advanced Prostate Cancer. This program utilizes the innovative AliveSim platform, offering real-life clinical case scenarios to work through in a low-stress environment with guidance from experts in the field of Oncology.
Credit Hours:
- 1.00 AMA PRA Category 1 Credit™
Course Expires: 7.31.2025
This activity is supported by educational grants from Astellas, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC and Sun Pharmaceutical Industries, Inc.
Improving Outcomes in Advanced Prostate Cancer
Watch this certified, on-demand webcast featuring prostate cancer experts Tanya Dorff, MD, and Neal Shore, MD, FACS, to get up to date on the latest clinical data informing optimal care across the spectrum of prostate cancer, from high-risk biochemical recurrence to metastatic castration-resistant disease. This activity will address best practices and management strategies associated with optimal community-based patient care as well as highlight challenges and health inequities.
Credit Hours:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 0.50 Pharmacology
Course Expires: 9.24.2025
This Evenings in Oncology enduring program is supported by independent medical educational grants from Astellas, Sun Pharma and Janssen Biotech, Inc. and administered by Janssen Scientific Affairs, LLC
MULTIPLE MYELOMA
Examining and Addressing Disparities in Multiple Myeloma Treatment & Outcomes
Multiple myeloma (MM) is a currently incurable malignancy that is primarily characterized by immunodeficiency, malignant plasma cell proliferation, and osteolytic bone lesions. This activity will address health inequities and highlight the challenges and best practices associated with successful community-based approaches to patient care.
Credit Hours:
- 1.00 AMA PRA Category 1 Credit™
- 1,00 ANCC
Course Expires: 8.23.2025
This Evenings in Oncology on-demand program is supported by an independent medical educational grant from Regeneron Pharmaceuticals, Inc.
Empowering Progress in RRMM through Patient Simulations: Evidence, Sequencing, and Equity
In this immersive educational program, participants will expand their understanding of managing patients with Multiple Myeloma. This program utilizes the innovative AliveSim platform, offering real-life clinical case scenarios to work through in a low-stress environment with guidance from experts in the field of Oncology.
Credit Hours:
- 1.00 AMA PRA Category 1 Credit™
Course Expires: 8.28.2025
This activity is supported by an eindependent medical education grant from Regeneron Pharmaceuticals. Inc. and Sanofi.
Free CME/CE Oncology
CATEGORY: SOLID TUMOR
Current Treatment Paradigms for Head and Neck Cancers
Samual Francis, MD, MS
Credit Hours: 1.00 AMA PRA Category 1 Credit™ 1.00 ANCC
Course Expires: 4.20.2025
Melanoma Management in 2024
Jonathan Zager, MD, FACS, FSSO
Credit Hours: 1.00 AMA PRA Category 1 Credit™ 1.00 ANCC
Course Expires: 4.20.2025
Neuroendocrine Neoplasms: Not All Hoofbeats Are Horses
Jessica Guadagno, PA
Credit Hours: 0.75 AMA PRA Category 1 Credit™ 0.75 ANCC
Course Expires: 4.19.2025
Navigating the Terrain: Insights into the Current Landscape, Treatment Strategies, and a Clinical Trial of Triple Negative Breast Cancer
Rowena D. Meyer, MSN, RN, ANP-BC, ACNS-BC, ANP-C
Credit Hours: 0.75 AMA PRA Category 1 Credit™ 0.75 ANCC
Course Expires: 4.19.2025
Hitting the Target: Updates and Review in Genotype Directed Therapy for Non-Small Cell Lung Cancer
Jonathan David McGuirt PA-C, MPH
Credit Hours: 1.00 AMA PRA Category 1 Credit™ 1.00 ANCC
Course Expires: 4.19.2025
Updates in Management of Advanced Renal Cell Carcinoma: Making Sense of the Menu
Jacqueline Brown, MD
Credit Hours: 1.00 AMA PRA Category 1 Credit™ 1.00 ANCC
Course Expires: 4.19.2025
Expanding the Role of Immunotherapy: New Regimens for Use in the Adjuvant and Neoadjuvant Settings
Anthony J. Olszanski, RPh, MD
Credit Hours: 1.00 AMA PRA Category 1 Credit™ 1.00 ANCC
Course Expires: 4.19.2025
Improving Outcomes in Advanced Prostate Cancer - Patient Case Simulations
Tanya Barauskas Dorff, MD and Neal D. Shore, MD FACS
Credit Hours: 1.00 AMA PRA Category 1 Credit™
Course Expires: 7.31.2025
Improving Outcomes in Advanced Prostate Cancer
Tanya Barauskas Dorff, MD and Neal D. Shore, MD FACS
Credit Hours: 1.00 AMA PRA Category 1 Credit™ - 1.00 ANCC - 0.50 Pharmacology
Course Expires: 9.24.2025
Advancing Management Strategies in Metastatic Colon Cancer: Protocols, Targets, and Immunotherapies
Valerie Lee, MD
Credit Hours: 0.75 AMA PRA Category 1 Credit™ 0.75 ANCC
Course Expires: 1.22.2026
Role of Nutrition Support for Patients Receiving Radiation Therapy
Krystle Zuniga, PhD, RD, LD, CSO
Credit Hours: 1.0 AMA PRA Category 1 Credit™ 1.0 ANCC
Course Expires: 1.22.2026
Head and Neck Cancers: Role of Radiation and Systemic Treatments, Side Effects and Management Strategies
Keola Beale, MD and Susie Chen, MD
Credit Hours: 0.75 AMA PRA Category 1 Credit™ 0.75 ANCC
Course Expires: 1.22.2026
Comprehensive Risk Assessment and Management Strategies for High-Risk Breast Cancer Patients
Sarah Gelb, MSN, APRN, FNP-C
Credit Hours: 0.75 AMA PRA Category 1 Credit™ 0.75 ANCC - 0.50 Pharmacology
Course Expires: 1.22.2026
CATEGORY: HEMATOLOGY
Updates in Lymphoma 2024
Laura J. Zitella, MS, RN, ACNP-BC, AOCN
Credit Hours: 1.00 AMA PRA Category 1 Credit™ 1.00 ANCC
Course Expires: 4.19.2025
Expanding the Role of Immunotherapy: New Regimens for Use in the Adjuvant and Neoadjuvant Settings
Anthony J. Olszanski, RPh, MD
Credit Hours: 1.00 AMA PRA Category 1 Credit™ 1.00 ANCC
Course Expires: 4.19.2025
Revolutionizing Leukemia Treatment: Allogeneic Transplants, Engineered T Cell Therapy, and Navigating the Complexities of GVHD
Gary Schiller, MD, FACP
Credit Hours: 1.00 AMA PRA Category 1 Credit™ 1.00 ANCC
Course Expires: 4.19.2025
Empowering Progress in RRMM through Patient Simulations: Evidence, Sequencing, and Equity
Carrie Bellerive, BSN, BS, RN, BMTCN / Joseph Mikhael, MD, MEd, FRCPC, FACP / Beth Faiman, PhD, RN, MSN, APN-BC, BMTCN, AOCN, BMTCN, FAAN, FAPO
Credit Hours: 1.00 AMA PRA Category 1 Credit™
Course Expires: 8.28.2025
The Essential Guide to Acute Leukemia
Jennie Goble, DMSc, PA-C
Credit Hours: 1.00 AMA PRA Category 1 Credit™ - 1.00 ANCC
Course Expires: 9.19.2025
CRS/ICANS Unveiled: From Detection to Intervention
Alex Evans, PharmD, BCOP
Credit Hours: 0.50 AMA PRA Category 1 Credit™ 0.50 ANCC
Course Expires: 1.22.2026
Navigating the Landscape of Acute Leukemia: Understanding, Treat
Kerrin Sorrie, DNP, AGACNP-BC, AOCNP
Credit Hours: 1.0 AMA PRA Category 1 Credit™ 1.0 ANCC
Course Expires: 1.22.2026
The Road To and From the Transplant Center for Patients with AML
Lisa Getzendaner, PA-C, MHS
Credit Hours: 0.50 AMA PRA Category 1 Credit™ 0.50 ANCC
Course Expires: 1.22.2026
CATEGORY: GENERAL CANCER
Nutritional Strategies in Cancer Care: The Role of Enteral Nutrition
Krystle Zuniga, PhD, RD, LD, CSO
Credit Hours: 1.00 AMA PRA Category 1 Credit™ 1.00 ANCC
Course Expires: 4.20.2025
Integrative Oncology: Supporting Healing Before, During, and After
Dana Guyer, MD FAAHPM
Credit Hours: 1.00 AMA PRA Category 1 Credit™ 1.00 ANCC
Course Expires: 4.20.2025
THE PYRAMID: BUILDING BLOCKS FOR SUCCESSFUL ADVANCED CARE PLANNING
Melanie Smith, MD
Credit Hours: 1.00 AMA PRA Category 1 Credit™ 1.00 ANCC
Course Expires: 4.20.2025
Cardio-Oncology: Implications for Clinical Practice
Anecita Fadol, PhD, APRN, FNP, FAANP, FHKAN, FAAN
Credit Hours: 1.00 AMA PRA Category 1 Credit™ 1.00 ANCC
Course Expires: 1.22.2026
CATEGORY: GERONTOLOGICAL (CHECK BACK LATER)
Free CME/CE NON ONCOLOGY
Eosinophilic Esophagitis: An Update on the Latest Guidelines And Evidence for Improving Patient Outcomes (Through 2/12/25)
Horizon CME designates this enduring activity for a maximum of 1.5 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Taking a Deep Breath: Current and Emerging Strategies for Optimizing COPD Treatment (Through 3/1/25)
Horizon CME designates this enduring activity for a maximum of 1.25 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Breaking Barriers: Addressing Disparities in COPD Management (Through 4/15/25)
Horizon CME designates this enduring activity for a maximum of 0.25 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Innovative Approaches to Managing Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) (Through 3/19/25)
1.50 AMA PRA Category 1 Credit™ Horizon CME designates this Enduring activity for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Emerging Role of Biologics in COPD Management: An Expert Discussion (Through 10/9/25)
Horizon CME designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Optimal Management of Severe Asthma: A Roundtable Discussion (Through 10/15/25)
1.00 AMA PRA Category 1 Credit™ Horizon CME designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.